Richard Bucala
2026–2026 OpenAlex profile ↗
Reproducibility track record
1
assessed papers
29/100
mean reproducibility
0
reproduced (C1–C2)
1
flagged
0
total citations
flag rate:
100%
(1/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Xuanming Luo 1Jie Qi 1Peizhi Miao 1Junbo Ge 1Miyesaier Abudureyimu 1Xing Qin 1Rong Chen 1Jun Ren 1Guizhen Wang 1Yingmei Zhang 1
Institutions
Fudan University 1Shanghai Xuhui Central Hospital 1Tongji University 1Shanghai Pulmonary Hospital 1Shanghai Tenth People's Hospital 1Xijing Hospital 1
Geography (author institutions)
CN 1US 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (1)
Request a reproduction →1 assessed by us (0 reproduced) · 0 not yet assessed — every PubMed paper on record, linked below.
-
CD74 deficiency protects against doxorubicin cardiotoxicity through RRM2-mediated regulation of ferroptosis⚑Acta Pharmaceutica Sinica B · 2026 · PMID 42180553L1 29/100 ⚑
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
No ORCID on record to anchor it (≈⅓ of researchers have none), so this rests on name disambiguation alone. See every “Bucala R” paper on PubMed ↗